European "mad cow" disease risk materials 18-month phase-out recommended.
This article was originally published in The Tan Sheet
Executive Summary
EUROPEAN SPONGIFORM RISK MATERIALS 18-MONTH PHASE-OUT RECOMMENDED by the Committee on Proprietary Medicinal Products in a "provisional report" released after the group's meeting Oct. 20-23. "For products manufactured using derivatives of [specified risk materials], or other bovine-derived materials used as reagents, it would take manufacturers well into 1999 to change their production processes...to eliminate the use of such materials," the committee notes. "Hence, a substantial transition period of at least 18 months should be provided for any necessary changes." Therefore, European restrictions on use of such products should be applied prospectively after Jan. 1, and not retroactively to existing products without a suitable transition period, CPMP advises.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning